11 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33091395 | Novel mutations in ATP13A2 associated with mixed neurological presentations and iron toxicity due to nonsense-mediated decay. | 2021 Jan 1 | 2 |
2 | 32032734 | Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function. | 2020 Jun | 4 |
3 | 29169913 | The strategic function of the P5-ATPase ATP13A2 in toxic waste disposal. | 2018 Jan | 1 |
4 | 26818499 | Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's Disease. | 2016 Jan 27 | 6 |
5 | 27073711 | Protection against Mitochondrial and Metal Toxicity Depends on Functional Lipid Binding Sites in ATP13A2. | 2016 | 1 |
6 | 25912790 | The Parkinson-associated human P5B-ATPase ATP13A2 protects against the iron-induced cytotoxicity. | 2015 Aug | 7 |
7 | 24361204 | C19orf12 mutation leads to a pallido-pyramidal syndrome. | 2014 Mar 10 | 1 |
8 | 22743658 | Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts. | 2012 Aug 8 | 2 |
9 | 20310007 | ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. | 2010 Jun 15 | 2 |
10 | 20740487 | Response to: ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. | 2010 Oct 15 | 2 |
11 | 20817231 | Emerging parkinsonian phenotypes. | 2010 Oct | 1 |